Therefore, further study of the tumor microenvironment, especially the role of inflammatory cytokines, may provide new ideas for immunotherapy and a new development direction for the effective use of PD-L1/PD-1 inhibitors in cancer treatment. The gene discussed is PDCD1; the disease is neoplasm.